Viking Therapeutics
VKTX • NASDAQ
Viking Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brian Lian, with a market cap of $3.0B.
CEOBrian Lian
Market Cap$3.0B
Biotechnology
Healthcare
Employees30.0
Websitevikingtherapeutics.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Viking Therapeutics
Date
Wednesday, April 22, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.93
Earnings History
Past 11 earnings reports for Viking Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2025 | Q3 2025 | -$0.81Est: -$0.68 | -19.1% | - | — | — |
| Jul 23, 2025 | Q2 2025 | -$0.58Est: -$0.44 | -31.8% | - | — |  10-Q |
| Apr 23, 2025 | Q1 2025 | -$0.41Est: -$0.31 | -32.3% | - | — | 10-Q |
| Feb 5, 2025 | Q4 2024 | -$0.32Est: -$0.27 | -18.5% | - | — | 10-K |
| Oct 23, 2024 | Q3 2024 | -$0.22Est: -$0.25 | +12.0% | - | — | 10-Q |
| Jul 24, 2024 | Q2 2024 | -$0.20Est: -$0.27 | +25.9% | - | — | 10-Q |
| Apr 24, 2024 | Q1 2024 | -$0.26Est: -$0.28 | +7.1% | - | — | 10-Q |
| Feb 7, 2024 | Q4 2023 | -$0.25Est: -$0.26 | +3.8% | - | — | 10-K |
| Oct 25, 2023 | Q3 2023 | -$0.23Est: -$0.22 | -4.5% | - | — | 10-Q |
| Jul 26, 2023 | Q2 2023 | -$0.19Est: -$0.19 | 0.0% | - | — | 10-Q |
| Apr 26, 2023 | Q1 2023 | -$0.25Est: -$0.24 | -4.2% | - | — | 10-Q |